1-3 of 3
Heather Schroeder, RN
Close
Sort by
Journal Articles

Frontline Ofatumumab in Combination with Hyper-CVAD for Adult Patients with CD-20 Positive Acute Lymphoblastic Leukemia (ALL): Interim Result of a Phase II Clinical Trial

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Naval Daver, MD, Tapan M. Kadia, MD, Rita B. Khouri, Yesid Alvarado, MD, Jan A. Burger, MD PhD, Deborah A Thomas, MD, Guillermo Garcia-Manero, MD, Courtney D DiNardo, MD, Naveen Pemmaraju, MD, Nicholas J. Short, MD, Heather Schroeder, RN, Rebecca Garris, MS, Prithviraj Bose, MD, Nitin Jain, MD, Kiran Naqvi, MD, William G. Wierda, MD PhD, Srdan Verstovsek, MD PhD, Jorge E. Cortes, MD, Marina Konopleva, MD PhD, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2016) 128 (22): 2783.
https://doi.org/10.1182/blood.V128.22.2783.2783
Published: 2016
Journal Articles

A Randomized Study of Low Dose Oral Clofarabine 10 Mg Versus 20 Mg (flat dose) Daily × 5 for Patients with Higher-Risk Myelodysplastic Syndrome (MDS)

Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Zeev Estrov, MD, PhD, Gautam Borthakur, M.D., Susan M. O'Brien, MD, Tapan M. Kadia, M.D., Marina Konopleva, MD, PhD, Naval Daver, MD, Mark Brandt, BS, Heather Schroeder, RN, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2012) 120 (21): 3851.
https://doi.org/10.1182/blood.V120.21.3851.3851
Published: 2012
Journal Articles

Frontline Therapy for Older Patients (pts) with Acute Myeloid Leukemia (AML): Clofarabine Plus Low-Dose Cytarabine Induction Followed by Prolonged Consolidation with Clofarabine Plus Low-Dose Cytarabine Alternating with Decitabine

Stefan Faderl, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Xuelin Huang, PhD, Elias Jabbour, MD, Tapan Kadia, MD, Alessandra Ferrajoli, MD, Zeev Estrov, MD, Jennie Feliu, RN, Heather Schroeder, RN, Monica Kwari, BSN, Hagop Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 336.
https://doi.org/10.1182/blood.V116.21.336.336
Published: 2010